Advanced Search

 

Study ID Status Title Patient Level Data
113417 Completed Insulin resistance as primary pathogenesis in newly diagnosed, drug naïve type 2 diabetes patients in Korea
113423 Completed A randomised, double-blind, double-dummy, single dose, four way cross-over study to compare the pharmacokinetics and pharmacodynamics of GSK961081 and fluticasone propionate when administered alone, concurrently and as a combination blend in healthy subjects Study Listed on ClinicalStudyDataRequest.com
113434 Completed A randomised, double-blind, placebo-controlled study of topical GW870086X formulation in subjects with moderate or severe atopic dermatitis Study Listed on ClinicalStudyDataRequest.com
113435 Completed A randomised, double-blind (for GW870086), placebo-controlled study of topical GW870086 formulation to explore the potential for skin thinning in healthy adult volunteers Study Listed on ClinicalStudyDataRequest.com
113440 Completed A study to evaluate the safety and immunogenicity of A/California/7/2009 (H1N1)v-like vaccines GSK2340273A and GSK2340274A in adults aged 18 years and older Study Listed on ClinicalStudyDataRequest.com
113456 Completed Safety and immunogenicity study of GSK Biologicals’ influenza vaccine GSK2340272A in adults aged 18 to 60 years Study Listed on ClinicalStudyDataRequest.com
113459 Completed Safety and immunogenicity study of GSK Biologicals’ influenza vaccine GSK2340272A in adults aged 18 years and above Study Listed on ClinicalStudyDataRequest.com
113462 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 6 to 35 months Study Listed on ClinicalStudyDataRequest.com
113463 Completed An Open-Label Study to Characterize the Absorption, Distribution, Metabolism and Elimination of a Single Oral 14C Labeled Dose of GSK2118436 in Subjects with BRAF Mutant Solid Tumors
113468 Completed An Open-Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects with BRAF Mutation-Positive Tumor
113476 Completed A study to investigate the psychomotor and cognitive effects of alcohol when co-administered with GSK1144814 or matching placebo in healthy subjects.
113477 Completed An open-label, randomised, two-way crossover study, to evaluate and compare the pharmacokinetics of fluticasone furoate, administered from a novel dry powder device (repeat dose) and intravenously (single dose), in healthy Caucasian, Japanese, Korean and Chinese subjects Study Listed on ClinicalStudyDataRequest.com
113479 Completed Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered with an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects with BRAF Mutant Solid Tumors
113480 Completed A study to evaluate the safety, immunogenicity, and relative efficacy of A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340273A in adults aged 18 years and older Study Listed on ClinicalStudyDataRequest.com
113482 Completed A study to evaluate the safety and immunogenicity of A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340273A in children 6 months to less than 9 years of age Study Listed on ClinicalStudyDataRequest.com
113483 Completed A study to evaluate immune responses following A/California/7/2009 (H1N1)v-like virus vaccination given 4 months following seasonal influenza vaccination in adults 19 to 40 years of age Study Listed on ClinicalStudyDataRequest.com
113486 Completed An Open-Label, Phase I/Ib Dose Escalation Study to Assess the Safety and Tolerability of GSK1120212 in Combination with Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or nab-Paclitaxel in Subjects with Advanced Solid Tumors
113487 Completed A Randomized, Double-Blind Placebo-Controlled Phase II Study of the MEK inhibitor GSK1120212 plus Gemcitabine vs Placebo plus Gemcitabine in Subjects with Metastatic Pancreatic Cancer
113489 Completed An assessment of the Independent effect of oral antidiabetic agents and insulin exposure on the risk of myocardial infarction in type 2 diabetic patients
113489_1 Completed An assessment of the Independent effect of oral antidiabetic agents and insulin exposure on the risk of myocardial infarction in type 2 diabetic patients
113489_2 Completed An assessment of the Independent effect of oral antidiabetic agents and insulin exposure on the risk of myocardial infarction in type 2 diabetic patients
113492 Completed Balanced cohort study of thiazolidinediones (TZDs) and other antidiabetic therapies and coronary heart disease events
113492_1 Completed Balanced cohort study of thiazolidinediones (TZDs) and other antidiabetic therapies and coronary heart disease events
113492_2 Completed Balanced cohort study of thiazolidinediones (TZDs) and other antidiabetic therapies and coronary heart disease events
113497 Completed Reports of neoplasms in rosiglitazone clinical trials

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.